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Although the effectiveness of mammography for women under the age of 50 years with a family history of breast cancer (FHBC) has
not yet been proven, annual screening is being offered to these women to manage breast cancer risk. This study investigates women’s
awareness and interpretation of their familial risk and knowledge and views about mammographic screening. A total of 2231 women
from 21 familial/breast/genetics centres who were assessed as moderate risk (17–30% lifetime risk) or high risk (430% lifetime risk)
completed a questionnaire before their mammographic screening appointment. Most women (70%) believed they were likely, very
likely or definitely going to develop breast cancer in their lifetime. Almost all women (97%) understood that the purpose of
mammographic screening was to allow the early detection of breast cancer. However, 20% believed that a normal mammogram
result meant there was definitely no breast cancer present, and only 4% understood that screening has not been proven to save lives
in women under the age of 50 years. Women held positive views on mammography but did not appear to be well informed about
the potential disadvantages. These findings suggest that further attention should be paid to improving information provision to
women with an FHBC being offered routine screening.
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In the United Kingdom, as part of the national screening
programme, routine mammographic screening is only offered to
women aged over 50 years. However, women aged under 50 years
who are assessed as having a moderate (17–30% lifetime risk) or
high (430% lifetime risk) risk of developing breast cancer
are offered annual mammograms. Some women will be eligible
for genetic testing, but the majority of women with a family history
of breast cancer (FHBC) will have their risk managed through
annual mammographic screening as recommended by manage-
ment guidelines (National Institute for Clinical Excellence, 2004).
It has been increasingly recognised as important that individuals
make an informed choice regarding whether or not to participate
in screening (National Screening Committee, 2000). For women
with an FHBC, being informed means knowing not only what
having an increased risk means in terms of how likely they are to
develop breast cancer but also knowing about the advantages and
disadvantages of screening before 50 years of age. However, many
women with an FHBC may not have been fully informed. For
example, it has been reported that recall of risk level may be
inaccurate after counselling about the risk of developing breast
cancer (Hopwood et al, 2003) and that inaccuracies in risk
perception may persist (Leventhal et al, 1999; Hopwood et al, 2003;
d’Agincourt-Canning, 2005). Furthermore, studies of UK women
aged over 50 years in routine screening (Webster and Austoker,
2006) other general populations (Woloshin et al, 2000; Chamot and
Perneger, 2001; Silverman et al, 2001; Domenighetti et al, 2003)
and in women aged under 50 years (Black et al, 1995; Nekhlyudov
et al, 2003) have reported that women’s knowledge about
mammography is variable and sometimes incorrect.
To our knowledge, this study is the first large, multicentre UK
study to elicit the views and knowledge of women with an FHBC
regarding mammographic screening. The following key questions
are addressed: (1) What do women know about their level of breast
cancer risk? (2) What do women know about the purpose, possible
consequences and the effectiveness of mammography? (3) What
are women’s views about having a mammogram?
MATERIALS AND METHODS
Participants
A total of 3740 women were invited to participate in the study if
they were aged 35–49 years and had been accepted on an annual
screening programme after they had been assessed at specialist Received 7 May 2008; revised 13 August 2008; accepted 22 August 2008
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sfamily/breast/genetics clinics as being at moderate or high risk of
familial breast cancer. Women were excluded if they had a
previous diagnosis of breast cancer, an ovarian only family history
or were deemed to be low risk.
Familial risk assessment and acceptance on a family history
programme followed a similar pattern in the clinics participating
in the study. The women were referred to specialist clinics by their
general practitioner (GP) or by hospital consultants (e.g., breast
surgeons). All women referred to the clinics were asked to
complete a family history questionnaire, which was used to assess
risk levels. Assessment into a moderate or high risk category was
in accordance with the NICE guidelines published in 2004
(National Institute for Clinical Excellence, 2004). Both moderate
and high-risk women were offered regular mammograms at 1 year
to 18-month intervals and were counselled by a health professional
from the specialist clinics. In addition, all high-risk women were
offered referral to a genetics specialist for counselling. If eligible or
appropriate, high-risk women could also be offered genetic testing
or risk-reducing prophylactic surgery.
Procedures
Twenty-one centres running clinics for women with an FHBC
throughout the United Kingdom sent questionnaires with a reply
paid envelope to women 1 month (range 2 weeks to 4 months)
before their scheduled mammogram appointment. Where time
permitted, centres sent a reminder to women who did not return
their questionnaire within 2 weeks.
Women who missed one appointment and failed to contact the
clinic within 2 months, or those that missed two or more appoint-
ments were classified as non-attenders. These women were sent a
brief non-attendance questionnaire to elicit their reasons for not
attending.
The London Multicentre Research Ethics Committee approved
the study.
Measures
The questionnaire included the following items
Socio-demographic measures Age, marital status, ethnicity, educa-
tional level, number of biological children and menopausal status.
Screening history Women were asked whether they had had
previous mammograms or previous recall for further tests.
Family history Screening centres categorised women as either
moderate or high risk. Women provided information on whether a
first-degree family member had died of breast cancer or was
currently being treated for breast cancer.
Concerns about breast cancer Cancer Worry Scale Revised
(Lerman et al, 1991a,b; Watson et al, 1998). This six item
questionnaire assesses the degree of worry about developing
cancer and the impact of worry on daily functioning in the
previous month (Hopwood et al, 2001; Brain et al, 2002; Fry et al,
2003; Henderson et al, 2008).
The Psychological Consequences Questionnaire (Cockburn et al,
1992) is a 12-item questionnaire, which measures negative
consequences of breast screening in terms of emotional, physical
and social functioning in the previous month (Ong et al, 1997;
Tyndel et al, 2007).
Awareness of being at risk of breast cancer Women were asked
when they first realised they were at risk of breast cancer. They
were also asked ‘Have you been told what your level of risk of
developing breast cancer is?’ (no/don’t know/yes) and ‘if yes, what
were you told your level of risk is?’ (low/moderate/high or please
describe in your own terms).
Risk perception Perception of likelihood of breast cancer
was measured by asking women ‘how likely do you think it is
that you will develop breast cancer in your lifetime?’ The question
was scored from 1 (definitely) to 5 (no chance). Responses were
dichotomised by combining ‘definitely, highly likely and likely’
and ‘unlikely, no chance’ for analysis.
Perception of comparative risk of breast cancer was measured
by asking women ‘Compared to most other women your age, do
you think your own chances of getting breast cancer at some time
in you life are?’ The question was scored from 1 (much more) to
5 (much less). Both these questions were developed from previous
research (Hopwood et al, 2003). Responses were dichotomised by
combining ‘much more, a little more’ and ‘about the same, a little
less, much less’ for analysis.
Knowledge Women were asked several questions to gauge their
knowledge about the purpose, possible consequences and effec-
tiveness of mammography. There were six multiple choice
response options for each question, apart from the last item that
consisted of three. Women were also given the option to respond
‘don’t know’ to any of the questions. Responses to the questions
were scored as either correct or incorrect. Correct responses are
given in brackets. The questions were as follows:
(1) What do you think the main purpose of breast screening
(mammography) is? (to allow the early detection of breast cancer).
(2) Of women who go along for a routine screening mammo-
graphy about how many do you think will be given a normal
result (most of them).
(3) If, after a mammogram, a woman is given a normal result what
do you think this means? (highly unlikely or unlikely breast
cancer is present).
(4) After a mammogram, women may be called back because the
appearance of the x-ray suggests further tests are needed. How
often do you think this happens? (sometimes).
(5) Of the women who are called back for further tests after their
mammogram, about how many will turn out to have breast
cancer (some or a few).
(6) Mammography has been proven to save lives from breast
cancer in women under the age of 50 years with a family
history like yours (false)
Views on mammographic screening Attitudes towards mammo-
graphic screening were measured using an eight-item scale. The
questionnaire aimed to measure both positive and negative attitudes
to mammography. Women were asked how much they agreed with
four positive statements such as ‘Having breast screening (mammo-
graphy) would make me feel that I am doing something positive about
my risk of breast cancer’ and four negative statements such as ‘Having
breast screening (mammography) would be a frightening experience
for me’. Items are scored from 1 to 3 (strongly agree/agree), 4 (neither
agree nor disagree) and 5–7 (disagree/strongly disagree). The eight
items were factors analysed using principal components analysis,
which revealed two components: a positive (Cronbach’s a¼0.72) and
an e g a t i v e( C r o n b a c h ’ sa¼0.54). Responses to the positive compo-
nent were dichotomised into agree (4–12) and neutral/disagree
(13–28) for further analysis. The negative component was not
analysed further because of the low Cronbach a-score.
Reasons for non-attendance Women were presented with 21
statements of reasons for not attending the clinics plus an option
to add their own views and were also asked to identify up to three
main reasons for not attending.
Statistical analysis
A descriptive analysis was conducted to explore women’s knowl-
edge and views. Percentages and 95% confidence intervals are
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spresented. Further exploratory analyses to investigate differences
between groups were conducted using the w
2 test and t-test as
appropriate. The Yates continuity correction was used when
comparisons were made between dichotomised variables. Age and
cancer worry scores (CWS-R, PCQ) were treated as continuous
variables. Owing to the large number of comparisons being made,
only results that reached a level of significance of o0.01 were
considered statistically significant.
RESULTS
Study participants
After ineligible women were excluded, that is, those who
completed the questionnaire after their mammogram or 44
months before their mammogram (244), or did not fulfil the
inclusion criteria (222), 2321 women completed the pre-screening
questionnaire giving a response rate of 62% (2321 out of 3740). In
this study, 52 out of 2321 (2%) who completed the pre-screening
questionnaire did not attend their mammogram appointment. The
sociodemographic, screening history, family history and psycho-
logical variables of the whole sample are listed in Table 1.
Beliefs about risk and likelihood of developing breast
cancer
Awareness of breast cancer risk Of 439 women participating in
the programme for the first time, 38% (95% CI: 33.9–43.2)
reported being aware that they were at increased risk 45 years
ago. Seventeen per cent (95% CI: 13.9–21.2%) of women reported
realising they were at risk o6 months ago.
Knowledge of level of breast cancer risk Out of the total
cohort, 73% (95% CI: 71–74.7) reported they had been told their
risk level and 63% (95% CI: 60.5–64.5) reported what they had
been told. Of the 1435 women who reported their risk, compared
with clinic-risk level, 69% (95% CI: 66.0–70.9) reported their
risk correctly. Of the 782 moderate-risk women, 17% (95% CI:
14.8–20.2) underestimated their risk, 16% (95% CI: 13.4–18.6)
overestimated and 67% (95% CI: 63.3–70) reported their risk
correctly. Of the 653 high-risk women, 71% (95% CI: 66.9–74.1)
correctly reported their risk and 29% (95% CI: 25.9–33.1)
underestimated their risk.
Of the 1731 women who had been attending a screening
programme for more than 1 year, 27% (95% CI: 24.4–28.6) reported
they had not been told their risk or that they did not know if they
had been told their risk level. These women were significantly less
likely to have had higher (college or university) education (26 vs
34%; Po0.000) and significantly less likely to be high risk (28 vs
48%; Po0.000) than the women who had been told their risk.
Perceived risk of developing breast cancer When asked how likely
they think it was that they would develop breast cancer in their
lifetime, 20% (95% CI: 18.3–21.5) of the women reported not
knowing. This was significantly related to whether women
reported being told their risk (35 vs 25%; Po0.001) and these
women also tended to have lower levels of education (77 vs 67%;
Po0.001) and to be moderate risk (68 vs 56%; Po0.001).
Of the 1826 women in the total cohort who believed they did
know their likelihood of developing breast cancer, 87% (95% CI:
85.8–88.9) believed they may develop the disease. Comparisons
between high-risk and moderate-risk women showed that those at
high risk were significantly more sure of the likelihood of deve-
loping breast cancer (93 vs 83%; Po0.001). Two per cent (95% CI:
1.8–3.1) of the women believed they would definitely develop
cancer. There were no significant differences in whether these
women had been assessed as moderate or high risk or whether the
women had been told their actual risk level. But as these numbers
are very small, these results should be interpreted with caution.
Women were also asked to rate their own chances of developing
breast cancer compared with most other women their age. Of the
2210 women who answered the question, 87% (95% CI: 85.3–88.1)
believed that their chances of getting cancer were ‘a little more’ to
‘much more’ than most other women of their age and high-risk
women were significantly more sure that their risk was higher than
other women (93 vs 83%; Po0.001).
Knowledge of purpose, possible consequences and
effectiveness of mammography
Almost all women (97%; 95% CI: 96.6–97.9) reported that the
main purpose of mammography is the early detection of breast
cancer. The majority of women (75%; 95% CI: 72.7–76.3) knew
that most women would be given a normal result and 77% (95%
CI: 75.6–77.1) knew that following a mammogram, women
were ‘sometimes’ recalled for further tests. Similar numbers
overestimated recall (9%; 95% CI: 8.1–10.5) as underestimated it
(7%; 95% CI: 5.7–7.8). Eighty-six per cent (95% CI: 84.5–87.4) of
women knew that not all women recalled would be diagnosed with
cancer. A small number (4%; 95% CI: 3.4–5.1) thought incorrectly
that ‘most’ women recalled would be diagnosed with cancer. Only
4% (95% CI: 3.0–4.6) of women knew that mammography had not
been proven to save lives from breast cancer in women under the
age of 50 years with a family history and 20% (95% CI: 18.7–22) of
women thought that a normal result after a mammogram meant
that there was definitely no breast cancer present.
Views on mammography
Ninety per cent (95% CI: 88.7–91.2) of women felt that having a
mammogram would reassure them that everything was OK and
96% (95% CI: 95–96.7) felt that having a mammogram would
make them feel they were doing something positive. Eighty-one
per cent (95% CI: 79.3–82.5) of women felt that having a
mammogram would make them feel less anxious about breast
cancer and 78% (95% CI: 76.6–80.1) felt that it would reduce their
chances of dying of breast cancer. However, 35% (95% CI: 32.5–
36.5) felt that mammograms would be painful, 14% (95% CI: 12.7–
15.6) felt that having a mammogram would be frightening,
Table 1 Characteristics of participants summarised by level of risk
Level of risk
Characteristics
Moderate
N¼1350
High
N¼957
Sociodemographic
Age (median age range) 43 (35–49)** 42 (35–49)
Married/living with a partner (%) 1078 (80) 763 (80)
College/university education (%) 413 (31) 283 (30)
White (%) 1290 (96) 920 (96)
Biological children (%) 1090 (81) 763 (80)
Post-menopausal (%) 213 (16) 138 (14)
Family history
Relative died from breast cancer (%) 946 (70)** 789 (82)
Relative being treated for breast
cancer (%)
312 (23)** 278 (29)
Screening history
First mammogram (%) 198 (15) 121 (13)
First time in screening
programme (%)
270 (20) 164 (17)
Cancer worry
CWS mean (s.d.) 11.08 (3.06)** 11.67 (3.20)
PCQ median (range) 2 (0–36)** 3 (0–36)
**Po0.01.
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s16% (95% CI: 14.6–17.7) felt that having a mammogram would
make them worry about the effects of radiation and 8% (95% CI:
6.5–8.7) felt that having a mammogram would make them worry
unnecessarily.
Most of the women were positive about mammography.
However, 12% (95% CI: 10.9–13.7) of women scored highly on
the positive scale, indicating a greater level of disagreement. There
were no significant differences between baseline characteristics of
these women (cutoff Po0.01). But, these women were more
distressed (CWS: 12.2 vs 11.1: P¼0.000 and PCQ: 8.4 vs 5.6;
P¼0.000). They were also more likely be incorrect about how
many women would have a normal result (33 vs 24%; P¼0.001),
more likely to be correct about what a normal result means (86 vs
78%; P¼0.006), be more pessimistic about how many recalled
women would be diagnosed with cancer (20 vs 13%; P¼0.002)
and believe that mammography has not been proven to save lives
(8 vs 3%; P¼0.000).
Reasons for non-attendance at the screening appointment
Fifty-four per cent (95% CI: 39.5–67.8) completed a questionnaire
on reasons for non-attendance. Table 2 gives the frequency of
response to different reasons for non-attendance. It also shows
what the main reasons were for not attending for mammography.
The main reasons given were practical with the reason given by the
most number of women being ‘having problems getting to the
breast care unit’. Only three women reported that being anxious
about the possible outcome was a main barrier to attendance.
Summary of results
Most women had been aware of their increased risk for several
years before attending the screening programme. Not all women
reported that they had been told their risk level and of those who
did, the majority reported the level correctly, but a substantial
minority reported it incorrectly. Regardless of the level of risk,
most women believed that they may develop breast cancer in their
lifetime. Women in this cohort were very motivated to attend
screening and the majority had positive views about mammo-
graphic screening. The women who had less positive views
about mammography tended to report higher cancer-specific
distress. The majority of women responded correctly to the
questions about the purpose and possible consequences of
mammography. However, some were incorrect about the sensiti-
vity of mammography, and nearly all were incorrect in believing
that mammography had been proven to decrease mortality in
women under the age of 50 years. Comparisons of the relationship
between views and knowledge showed that the women who were
less positive about mammography were more likely to under-
estimate a good outcome.
DISCUSSION
Even before attending a familial breast clinic, many of the women
in this study had been aware that they may be at risk of developing
breast cancer for several years, and it has been suggested that
obtaining information about personal risk is a primary motivation
for attending a familial breast clinic (Brain et al, 2000). However,
although all of the clinics in this study reported that risk
counselling was provided as part of the screening programme,
some of the women who had participated in the programme for
more than 1 year stated they had not been told what their risk
levels were. As significantly less well-educated women recalled
being told their risk, this may have been due to a lack of
understanding of complex information. However, as significantly
more high-risk women reported being told their risk level, it could
Table 2 Reasons given for not attending the mammography appointment
Reasons given Number
a Main reason
b
Physical constraints
1. I had work commitments 53
2. I was on holiday. 42
3. I had problems attending due to my disability 3 1
4. I was not well 42
5. I had to care for a dependent 1
6. I had problems getting to the breast care unit (includes 13. The times were inconvenient) 8 4
7. I forgot 52
20. I have just had a mammogram elsewhere 5 2
Other – moved and not referred yet to new clinic 1
Sub-total 36
Concern about having a mammogram
8. I do not think it is beneficial for me 1
9. I was worried it would be painful 31
10. The benefits of mammography have not been proven 2
11. The last experience discouraged me 1
12. Someone else has put me off 1
14. I was anxious about the possible outcome of screening (i.e., anxious about my results) 7 3
15. I would prefer not to know if something was wrong. 1 1
16. I was worried about the effects of radiation 4 2
17. I don’t trust the medical profession 21
18. I examine myself for lumps 1
19. I prefer an alternative approach 11
Other – Want MRI scans instead of X-rays 1
Other – Told not high risk 11
Other – GP-negative attitude because already had several mammograms 1 1
Sub total 27
Total 63
aWomen may have given more than one reason for not attending.
bWomen may have given up to three main reasons for not attending.
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to high-risk compared with moderate-risk women.
Of those who stated that they had been told their risk level, 69%
accurately reported the same risk level as the clinic assessment.
This is similar to rates reported in other studies (Hopwood et al,
2003). Although accurately recalling risk level does not necessarily
accord with women’s perception of their vulnerability (Hopwood
et al, 2003), in this study the high-risk women were more likely to
believe that they may develop breast cancer in their lifetime.
Another primary motivation for attending a family history clinic
is to be advised on strategies to deal with familial risk (Brain et al,
2000). For the majority of women, the only strategy available is
mammographic surveillance. However, clinicians are concerned
about the low sensitivity in younger women with denser breasts.
The MARIBS study (Leach et al, 2005), which compared the
sensitivity of different screening techniques in high-risk women in
this age range, reported that mammography has a 40% sensitivity.
However, a number of women in this study tended to over-rate
the sensitivity of mammography; 20% believed that a normal
result meant there was definitely no cancer present and the
overwhelming majority did not know that mammographic screen-
ing had not been proven to save lives in the younger age group.
The absence of definitive proof for mortality reduction from
mammography in younger women does by no means constitute
proof of absence of such an effect. However, there is a debate in the
medical world whether there is proof that screening women aged
between 40 and 49 years reduces mortality. Evidence of mortality
reduction has come from a number of meta-analyses of trials
(Smart et al, 1995; Hendrick et al, 1997; Kerlikowske, 1997; Moss
et al, 2006). However, the conclusions have remained controversial
for several reasons, including concerns about data that came from
trials not specifically designed to evaluate younger women, the
quality of the design of some of the trials, the effect of beginning
screening at ages just before 50 years and the end points that were
measured (Olsen and Gotzsche, 2001). The Age trial (Moss et al,
2006), which was designed specifically to measure the effect of
screening in younger women, concluded that although there was a
reduction in breast cancer mortality in the screened group
compared with those not being screened, this was not significant.
As they point out, this may be due to the diminished power of the
trial (60% to detect a 20% mortality reduction) caused by a smaller
than planned sample and a lower than anticipated mortality from
breast cancer in the control group, which is probably due to
improvements in treatment and consequent survival.
Because women with a family history of breast cancer are at
greater risk, in the United Kingdom they are recommended to begin
annual mammography screening from the age of 40 years. However,
there are theoretical concerns that screening may induce breast
cancers in these women, as they may have a genetic susceptibility to
radiation, for example, women with BRAC mutations are likely to be
more sensitive to ionising radiation as BRAC genes are integral in
repairing breast cells (Powell and Kachnic, 2003). They could also
comprise a ‘high-dose’ subgroup, as they begin mammography
screening at a younger age, have a greater lifetime cumulative
exposure to radiation and are more likely to be recalled for further
tests. However, no randomised trials have been conducted with this
population. Furthermore, as women with a family history of breast
cancer are already being offered annual mammography, it would
not be feasible to conduct a randomised trial in this population in
the United Kingdom. There is. however, a large prospective study
ongoing in the United Kingdom (FH01) (Mackay et al, 2001), which
is due to report in 2010.
In this study, the number of women not attending mammo-
graphy screening was very small and the main barriers to
attendance were practical ones. This reflects the findings in a
previous study, which found that once accepted on a family history
programme women are highly motivated to attend mammographic
screening. Lalloo et al (1998) reported that attendance rates at a
single UK clinic for first and subsequent screens were 95.2 and
98.9%, respectively. This may be because women with an increased
perception of breast cancer risk are more likely to participate in
screening in an attempt to gain control over the disease (Katapodi
et al, 2004). Another possibility could also be that participating in
what is generally seen as a health responsible behaviour may be a
way of pre-empting feelings of self-blame (Silverman et al, 2001) if
women do develop breast cancer. This view may be further
reinforced by having the option to participate in a screening
programme, which is not offered to others in the same age range
without an FHBC. The high attendance also suggests that the
majority of women with an FHBC may not be making an informed
choice when attending mammography screening. Although
making an informed choice is recognised as important, there are
concerns that given the lack of options available for screening
women with an FHBC, knowledge of the uncertainty about its
effectiveness in younger women may increase levels of anxiety.
Although this study was large and recruited women from
throughout the United Kingdom, there is still a possibility of non-
response bias, and the results may not be representative of all women
offered the option of participating in a mammographic screening
programme because of an FHBC. The strength of the study is that it
is the first large multicentre UK study to measure knowledge and
views about mammography in women with an FHBC.
In conclusion, once a woman’s increased risk level has been
confirmed by health professionals, the only strategy for managing
this risk for the majority of women is to participate in an annual
mammography screening programme despite the uncertainty at
present as to the effectiveness of mammography in this group of
women. The results from this study highlight that some women
have an overly optimistic view of the role mammography may play
in reducing breast cancer mortality. Further attention should be
given to providing women with an FHBC information about the
potential benefits and limitations of mammographic screening,
including its lack of sensitivity. It may also be beneficial if the
essence of the debate is communicated to women.
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